Several years ago, when Equity.Guru boss Chris Parry was writing at Stockhouse, he was called out to a new client – a company called Abattis Bioceutical (ATT.C). Abattis execs…
Abattis Bioceuticals
The Canadian Securities Exchange is not known for rigorous compliance protocols. However, it does have some standards, and cannabis health product company Abattis Bioceuticals (ATT.C) was unable to meet…